Raquel Coca Lopez

Raquel Coca Lopez has extensive work experience in the pharmaceutical industry. Raquel is currently serving as the Chief Commercial Officer (CCO) at Daiichi Sankyo, Inc. since November 2022. Prior to this role, they held various positions at Novartis Oncology, including Business Excellence & Operations Head (BEO), BD&L and Mature Products Head, and Business Franchise Head Hematology. From 2013 to 2019, Raquel worked at Novartis, where they held multiple roles such as National Sales Head (Dermatology/Rheumatology), Dermatology Marketing Director, Business Op. & Strat. Projects Head, Business Franchise Head, Sales Manager, and Team Leader Fibrosis Quistic. Before joining Novartis, Raquel worked at Merck as a Health Science Associate and at Pfizer as a Sales Representative. Raquel'sexperience includes responsibilities such as developing sales strategies, managing regional teams, implementing marketing strategies, and coordinating projects.

Raquel Coca Lopez completed their Bachelor of Science degree in Pharmaceutical Sciences from Universidad de Salamanca from 1995 to 2000. Raquel also pursued a Master's degree in Health Economics and Pharmaeconomics from Universitat Pompeu Fabra from 2007 to 2008. In 2002, Raquel obtained a Master's degree in International Business Administration from EAE Business School. Raquel furthered their education by completing a Master's in leadership and management from the University of Basel between 2014 and 2015. Recently, in 2019 and 2020, they acquired a Scrum Master certification from Scrum 101, specializing in Agile methodology. Additionally, Raquel attended Nottingham Trent University for an International Masters program in Business Administration, International Marketing, and Management, although the exact years are not specified.